Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study

Oncology ◽

10.1159/000350841 ◽

2013 ◽

Vol 85 (1) ◽

pp. 44-52 ◽

Author(s):

Chih-Hung Hsu ◽

Yoon Koo Kang ◽

Tsai-Shen Yang ◽

Chia-Tung Shun ◽

Yu-Yun Shao ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Hepatocellular Carcinoma ◽

First Line Therapy ◽

Asian Patients ◽

Multicenter Phase ◽

Download Full-text

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

Journal of Hepatology ◽

10.1016/j.jhep.2011.07.033 ◽

2012 ◽

Vol 56 (2) ◽

pp. 486-487 ◽

Author(s):

Jairo A. Garcia ◽

Lewis R. Roberts

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Advanced Hepatocellular Carcinoma ◽

Open Label Study ◽

Label Study ◽

First Line Therapy ◽

Download Full-text

Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international multicenter phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(01)81497-0 ◽

2001 ◽

Vol 37 ◽

pp. S272 ◽

Author(s):

C. Twelves ◽

C. Butts ◽

J. Cassidy ◽

Th. Conroy ◽

F. DeBraud ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Preliminary Results ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

International Multicenter

Download Full-text

A multicenter phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15520 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15520-15520 ◽

Author(s):

J. Kim ◽

H. Song ◽

Y. Do ◽

M. Kim ◽

K. Lee ◽

...

Keyword(s):

Esophageal Cancer ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy ◽

Squamous Cell Esophageal Cancer

Download Full-text

Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy for patients with advanced gastric cancer; first interim analysis of a randomised multicenter phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4015 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4015-4015 ◽

Author(s):

S.-E. Al-Batran ◽

J. Stöhlmacher ◽

S. Probst ◽

S. Hollerbach ◽

G. Wilhelm ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Interim Analysis ◽

Phase Ii Study ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

A nonrandomized, multicenter, phase II study of S-1 with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7602 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7602-7602

Author(s):

D. V. Jones ◽

C. Zergebel ◽

K. Saito ◽

A. Sandler

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell Lung ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy

The Oncologist ◽

10.1634/theoncologist.2020-0143 ◽

2020 ◽

Vol 25 (9) ◽

Author(s):

Zhong‐Zhe Lin ◽

Bang‐Bin Chen ◽

Yi‐Ping Hung ◽

Po‐Hsiang Huang ◽

Ying‐Chun Shen ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Hepatocellular Carcinoma ◽

Second Line ◽

Multicenter Phase

Download Full-text

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study

10.1186/s12885-015-1685-z ◽

2015 ◽

Vol 15 (1) ◽

Author(s):

Hitoshi Soda ◽

Hiromichi Maeda ◽

Junichi Hasegawa ◽

Takao Takahashi ◽

Shoichi Hazama ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text

933P Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.153 ◽

2021 ◽

Vol 32 ◽

pp. S819

Author(s):

J-L. van Laethem ◽

I. Borbath ◽

M. Karwal ◽

C. Verslype ◽

H. Van Vlierberghe ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Advanced Hepatocellular Carcinoma ◽

First Line Therapy ◽

Download Full-text

2353 Data from a phase Ib/II trial of the oral c-Met inhibitor tepotinib (MSC2156119J) as first-line therapy in Asian patients with advanced hepatocellular carcinoma

European Journal of Cancer ◽

10.1016/s0959-8049(16)31269-2 ◽

2015 ◽

Vol 51 ◽

pp. S452-S453 ◽

Author(s):

S. Qin ◽

H.Y. Lim ◽

B.Y. Ryoo ◽

C. Li ◽

H. Xiong ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Advanced Hepatocellular Carcinoma ◽

Phase Ib ◽

First Line Therapy ◽

Asian Patients ◽

Line Therapy ◽

Download Full-text

6098 POSTER CRAFT Trial-Result From Multicenter Phase II Study of Modified FOLFOX7 (Combination Chemotherapy of Infusional 5-FU/l-Leucovorin and Intermittent Oxaliplatin) With Bevacizumab in the First-line Therapy of Colorectal Cancer

European Journal of Cancer ◽

10.1016/s0959-8049(11)71743-9 ◽

2011 ◽

Vol 47 ◽

pp. S421

Author(s):

K. Ishibashi ◽

K. Koda ◽

M. Oshiro ◽

H. Matsuoka ◽

H. Baba ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Study ◽

Trial Result ◽

First Line Therapy ◽

Multicenter Phase ◽

Download Full-text